The timing is interesting. UnitedHealth has been under pressure for months, with its stock punished despite generating nearly $400 billion in annual revenue. Investors have been cautious, waiting for confirmation that the downtrend had run its course. That signal may have just arrived. After trading below its 50-day moving average, the stock broke back above the line, touching $300 in pre-market trading. Historically, these kinds of technical shifts precede stronger rallies, and in UnitedHealth’s case, the potential upside could be substantial. Traders are already eyeing gains of 80% to 100% from current levels, while long-term investors may prefer a move toward $400 before building larger positions.